Clinical laboratory assessment of the abuse liability of an electronic cigarette

ABSTRACT Aims  To provide an initial abuse liability assessment of an electronic cigarette (EC) in current tobacco cigarette smokers. Design  The first of four within‐subject sessions was an EC sampling session that involved six, 10‐puff bouts (30 seconds inter‐puff interval), each bout separated by...

Full description

Saved in:
Bibliographic Details
Published inAddiction (Abingdon, England) Vol. 107; no. 8; pp. 1493 - 1500
Main Authors Vansickel, Andrea R., Weaver, Michael F., Eissenberg, Thomas
Format Journal Article
LanguageEnglish
Published Oxford, UK Blackwell Publishing Ltd 01.08.2012
Blackwell
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:ABSTRACT Aims  To provide an initial abuse liability assessment of an electronic cigarette (EC) in current tobacco cigarette smokers. Design  The first of four within‐subject sessions was an EC sampling session that involved six, 10‐puff bouts (30 seconds inter‐puff interval), each bout separated by 30 minutes. In the remaining three sessions participants made choices between 10 EC puffs and varying amounts of money, 10 EC puffs and a varying number of own brand cigarette (OB) puffs, or 10 OB puffs and varying amounts of money using the multiple‐choice procedure (MCP). The MCP was completed six times at 30‐minute intervals, and one choice was reinforced randomly at each trial. Setting  Clinical laboratory. Participants  Twenty current tobacco cigarette smokers. Measurements  Sampling session outcome measures included plasma nicotine, cardiovascular response and subjective effects. Choice session outcome was the cross‐over value on the MCP. Findings  EC use resulted in significant nicotine delivery, tobacco abstinence symptom suppression and increased product acceptability ratings. On the MCP, participants chose to receive 10 EC puffs over an average of $1.06 or three OB puffs and chose 10 OB puffs over an average of $1.50 (P < 0.003). Conclusions   Electronic cigarettes can deliver clinically significant amounts of nicotine and reduce cigarette abstinence symptoms and appear to have lower potential for abuse relative to traditional tobacco cigarettes, at least under certain laboratory conditions.
Bibliography:ArticleID:ADD3791
ark:/67375/WNG-LHF3J25J-S
istex:08C816F0C88A09F34F4A545DC6D053A3384E6E44
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 14
ObjectType-Article-1
ObjectType-Feature-2
content type line 23
ISSN:0965-2140
1360-0443
1360-0443
DOI:10.1111/j.1360-0443.2012.03791.x